Suchergebnisse - "Sive, Jonathan"

PubPharm (8)

1

Adaptation of a multiple myeloma minimal residual disease multicolor flow cytometry assay for real-world practice

enthalten in: Cytometry. Part B, Clinical cytometry | 2023

von McMillan, A. | Tran, T. | Galas-Filipowicz, D. | +6

2

Daratumumab-bortezomib-dexamethasone use in relapsed POEMS syndrome

enthalten in: EJHaem | 2022

von Khwaja, J. | Keh, R. | Smyth, D. | +3

3

Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders : influence of host and disease factors

enthalten in: British journal of haematology | 2022

von Chan, W. | Howells, L. | Wilson, W. | +19

4

Development of antibody response to SARS-CoV-2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy

enthalten in: British journal of haematology | 2021

von Chan, W. | Sanchez, E. | Chavda, S. | +14

5

Defining Unmet Need Following Lenalidomide Refractoriness : Real-World Evidence of Outcomes in Patients With Multiple Myeloma

enthalten in: Frontiers in oncology | 2021

von Lecat, C. | Taube, J. | Wilson, W. | +13

6

Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy

enthalten in: British journal of haematology | 2020

von Cook, G. | John Ashcroft, A. | Pratt, G. | +14

7

Global hypomethylation in myeloma is associated with poor prognosis

enthalten in: British journal of haematology | 2016

von Sive, J. | Feber, A. | Smith, D. | +3

8

Global hypomethylation in myeloma is associated with poor prognosis

enthalten in: British journal of haematology | 2016

von Sive, J. | Quinn, J. | Feber, A. | +3

1
[1]